PRIMARY IMMUNODEFICIENCY DISEASES (PID)
Clinical trials for PRIMARY IMMUNODEFICIENCY DISEASES (PID) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY IMMUNODEFICIENCY DISEASES (PID) trials appear
Sign up with your email to follow new studies for PRIMARY IMMUNODEFICIENCY DISEASES (PID), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Researchers dig into records to see if Immune-Boosting drug is safe
Knowledge-focused Recruiting nowThis study looks back at medical records of 100 people in Japan with primary immunodeficiency (a weak immune system) who took the drug Cuvitru. The goal is to track serious side effects like allergic reactions, blood clots, and meningitis. No new treatments are given—just a revie…
Matched conditions: PRIMARY IMMUNODEFICIENCY DISEASES (PID)
Sponsor: Takeda • Aim: Knowledge-focused
Last updated May 26, 2026 11:22 UTC
-
Scientists test new gene fix for rare immune diseases in the lab
Knowledge-focused Recruiting nowThis study uses blood samples from 20 adults with primary immunodeficiency diseases to see how JAK inhibitors affect the immune system and whether a gene therapy approach can correct faulty immune cells. The goal is to gather knowledge that could lead to better treatments. Partic…
Matched conditions: PRIMARY IMMUNODEFICIENCY DISEASES (PID)
Phase: NA • Sponsor: prof. dr. Rik Schrijvers • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC